28081533|t|EEG Monitoring Technique Influences the Management of Hypoxic-Ischemic Seizures in Neonates Undergoing Therapeutic Hypothermia
28081533|a|Electroencephalogram (EEG) monitoring techniques for neonatal hypoxia-ischemia (HI) are evolving over time, and the specific type of EEG utilized could influence seizure diagnosis and management. We examined whether the type of EEG performed affected seizure treatment decisions (e.g., the choice and number of antiseizure drugs [ASDs]) in therapeutic hypothermia-treated neonates with HI from 2007 to 2015 in the Johns Hopkins Hospital Neonatal Intensive Care Unit. During this period, 3 different EEG monitoring protocols were utilized: Period 1 (2007-2009), single, brief conventional EEG (1 h duration) at a variable time during therapeutic hypothermia treatment, i.e., ordered when a seizure was suspected; Period 2 (2009-2013), single, brief conventional EEG followed by amplitude-integrated EEG for the duration of therapeutic hypothermia treatment and another brief conventional EEG after rewarming; and Period 3 (2014-2015), continuous video-EEG (cEEG) for the duration of therapeutic hypothermia treatment (72 h) plus for an additional 12 h during and after rewarming. One hundred and sixty-two newborns were included in this retrospective cohort study. As a function of the type and duration of EEG monitoring, we assessed the risk (likelihood) of receiving no ASD, at least 1 ASD, or ≥2 ASDs. We found that the risk of a neonate being prescribed an ASD was 46% less during Period 3 (cEEG) than during Period 1 (brief conventional EEG only) (95% CI 6-69%, p = 0.03). After adjusting for initial EEG and MRI results, compared with Period 1, there was a 38% lower risk of receiving an ASD during Period 2 (95% CI: 9-58%, p = 0.02) and a 67% lower risk during Period 3 (95% CI: 23-86%, p = 0.01). The risk ratio of receiving ≥2 ASDs was not significantly different across the 3 periods. In conclusion, in addition to the higher sensitivity and specificity of continuous video-EEG monitoring, fewer infants are prescribed an ASD when undergoing continuous forms of EEG monitoring (aEEG or cEEG) than those receiving conventional EEG. We recommend that use of continuous video-EEG be considered whenever possible, both to treat seizures more specifically and to avoid overtreatment.
28081533	0	3	EEG	T058	UMLS:C0013819
28081533	4	14	Monitoring	T058	UMLS:C1283169
28081533	40	50	Management	T058	UMLS:C0376636
28081533	54	79	Hypoxic-Ischemic Seizures	T038	UMLS:C0752304
28081533	103	126	Therapeutic Hypothermia	T058	UMLS:C0020674
28081533	127	147	Electroencephalogram	T033	UMLS:C1527380
28081533	149	152	EEG	T033	UMLS:C1527380
28081533	154	164	monitoring	T058	UMLS:C1283169
28081533	189	205	hypoxia-ischemia	T038	UMLS:C0752308
28081533	207	209	HI	T038	UMLS:C0752308
28081533	260	263	EEG	T033	UMLS:C1527380
28081533	289	296	seizure	T033	UMLS:C0036572
28081533	297	306	diagnosis	T033	UMLS:C0011900
28081533	311	321	management	T058	UMLS:C0376636
28081533	355	358	EEG	T058	UMLS:C0013819
28081533	378	385	seizure	T033	UMLS:C0036572
28081533	438	455	antiseizure drugs	T103	UMLS:C1254351
28081533	457	461	ASDs	T103	UMLS:C1254351
28081533	479	498	hypothermia-treated	T058	UMLS:C0150255
28081533	513	515	HI	T038	UMLS:C0752308
28081533	541	592	Johns Hopkins Hospital Neonatal Intensive Care Unit	T092	UMLS:C0021709
28081533	626	629	EEG	T033	UMLS:C1527380
28081533	630	640	monitoring	T058	UMLS:C1283169
28081533	641	650	protocols	T058	UMLS:C0008971
28081533	715	718	EEG	T058	UMLS:C0013819
28081533	772	793	hypothermia treatment	T058	UMLS:C0150255
28081533	816	823	seizure	T033	UMLS:C0036572
28081533	828	837	suspected	T038	UMLS:C0277540
28081533	888	891	EEG	T058	UMLS:C0013819
28081533	904	928	amplitude-integrated EEG	T058	UMLS:C0013819
28081533	961	982	hypothermia treatment	T058	UMLS:C0150255
28081533	1014	1017	EEG	T058	UMLS:C0013819
28081533	1024	1033	rewarming	T058	UMLS:C0206156
28081533	1061	1081	continuous video-EEG	T058	UMLS:C0430800
28081533	1083	1087	cEEG	T058	UMLS:C0430800
28081533	1121	1142	hypothermia treatment	T058	UMLS:C0150255
28081533	1195	1204	rewarming	T058	UMLS:C0206156
28081533	1263	1289	retrospective cohort study	T062	UMLS:C2985505
28081533	1333	1336	EEG	T033	UMLS:C1527380
28081533	1337	1347	monitoring	T058	UMLS:C1283169
28081533	1399	1402	ASD	T103	UMLS:C1254351
28081533	1415	1418	ASD	T103	UMLS:C1254351
28081533	1426	1430	ASDs	T103	UMLS:C1254351
28081533	1488	1491	ASD	T103	UMLS:C1254351
28081533	1522	1526	cEEG	T058	UMLS:C0430800
28081533	1569	1572	EEG	T058	UMLS:C0013819
28081533	1633	1636	EEG	T058	UMLS:C0013819
28081533	1641	1644	MRI	T058	UMLS:C0024485
28081533	1721	1724	ASD	T103	UMLS:C1254351
28081533	1863	1867	ASDs	T103	UMLS:C1254351
28081533	1994	2014	continuous video-EEG	T058	UMLS:C0430800
28081533	2015	2025	monitoring	T058	UMLS:C1283169
28081533	2059	2062	ASD	T103	UMLS:C1254351
28081533	2099	2102	EEG	T033	UMLS:C1527380
28081533	2103	2113	monitoring	T058	UMLS:C1283169
28081533	2115	2119	aEEG	T058	UMLS:C0013819
28081533	2123	2127	cEEG	T058	UMLS:C0430800
28081533	2163	2166	EEG	T058	UMLS:C0013819
28081533	2193	2213	continuous video-EEG	T058	UMLS:C0430800
28081533	2261	2269	seizures	T033	UMLS:C0036572
28081533	2301	2314	overtreatment	T058	UMLS:C4046039